|
Q4 2020
Filed on Feb 03, 2021
|
29
|
$21.66 - $38.74
$628 - $1.12K
|
|
|
Q4 2020
Filed on Feb 03, 2021
|
14
|
$39.24 - $82.11
$549 - $1.15K
|
|
|
Q4 2020
Filed on Feb 03, 2021
|
1,173
|
$32.56 - $60.8
$38.2K - $71.3K
|
|
|
Q4 2020
Filed on Feb 03, 2021
|
864
|
$53.77 - $69.21
$46.5K - $59.8K
|
|
|
Q4 2020
Filed on Feb 03, 2021
|
425
|
$59.45 - $70.41
$25.3K - $29.9K
|
|
|
Q4 2020
Filed on Feb 03, 2021
|
495
|
N/A
|
|
|
Q4 2020
Filed on Feb 03, 2021
|
14
|
$22.07 - $30.43
$309 - $426
|
|
Renaissance Cap Greenwich Fd
|
Q4 2020
Filed on Feb 03, 2021
|
900
|
N/A
|
|
|
Q4 2020
Filed on Feb 03, 2021
|
100
|
$37.88 - $52.07
$3.79K - $5.21K
|
|
|
Q4 2020
Filed on Feb 03, 2021
|
355
|
N/A
|
|
|
Q4 2020
Filed on Feb 03, 2021
|
1,324
|
N/A
|
|
|
Q4 2020
Filed on Feb 03, 2021
|
2,000
|
N/A
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
350
|
$26.39 - $32.14
$9.24K - $11.2K
|
|
Fiduciary Claymore Engry Inf
|
Q3 2020
Filed on Oct 30, 2020
|
691
|
N/A
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
139
|
$6.77 - $8.41
$941 - $1.17K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
2,716
|
$8.74 - $10.12
$23.7K - $27.5K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
53
|
N/A
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
19
|
$54.32 - $62.48
$1.03K - $1.19K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
47
|
$19.12 - $23.88
$899 - $1.12K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
650
|
$172.42 - $192.79
$112K - $125K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
150
|
$36.51 - $48.07
$5.48K - $7.21K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
64
|
N/A
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
420
|
$103.87 - $120.36
$43.6K - $50.6K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
53
|
$52.13 - $63.75
$2.76K - $3.38K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
43
|
$82.51 - $98.45
$3.55K - $4.23K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
6
|
N/A
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
23,386
|
N/A
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
400
|
N/A
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
47
|
$30.26 - $37.44
$1.42K - $1.76K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
271
|
$10.04 - $14.2
$2.72K - $3.85K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
1,258
|
$37.26 - $45.31
$46.9K - $57K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
30
|
$105.71 - $181.98
$3.17K - $5.46K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
21
|
$52.76 - $74.49
$1.11K - $1.56K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
38
|
$36.42 - $57.0
$1.38K - $2.17K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
1,878
|
$78.68 - $86.23
$148K - $162K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
40
|
$110.21 - $159.36
$4.41K - $6.37K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
304
|
$56.98 - $63.63
$17.3K - $19.3K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
20
|
$61.81 - $114.86
$1.24K - $2.3K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
15
|
N/A
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
120
|
$31.76 - $34.86
$3.81K - $4.18K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
15
|
$35.98 - $47.66
$540 - $715
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
5
|
$30.68 - $36.54
$153 - $183
|
|
Momenta Pharmaceuticals Inc
|
Q3 2020
Filed on Oct 30, 2020
|
52
|
N/A
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
0
|
$35.48 - $40.83
$0 - $0
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
130
|
$6.66 - $8.82
$866 - $1.15K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
17
|
$137.83 - $180.95
$2.34K - $3.08K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
400
|
$23.08 - $25.05
$9.23K - $10K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
3,170
|
$49.13 - $64.05
$156K - $203K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
750
|
$1.23 - $1.85
$923 - $1.39K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
8
|
$23.36 - $40.76
$187 - $326
|
|